These results, taken together, indicate that STAG2 inactivation may impair the ability of BRAF-mutant thyroid cancer cells to utilize glutamine and decrease the antioxidant capacity and ROS clearance of cells under glutamine stress condition. Here, STAG2 is linked to thyroid gland carcinoma.